These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24396336)

  • 1. Protease-activated receptors as therapeutic targets in visceral pain.
    Cenac N
    Curr Neuropharmacol; 2013 Dec; 11(6):598-605. PubMed ID: 24396336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The enteric nervous system in inflammation and pain: the role of proteinase-activated receptors.
    Vergnolle N
    Can J Gastroenterol; 2003 Oct; 17(10):589-92. PubMed ID: 14571293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of visceral pain and inflammation by protease-activated receptors.
    Vergnolle N
    Br J Pharmacol; 2004 Apr; 141(8):1264-74. PubMed ID: 15051630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome.
    Cenac N; Bautzova T; Le Faouder P; Veldhuis NA; Poole DP; Rolland C; Bertrand J; Liedtke W; Dubourdeau M; Bertrand-Michel J; Zecchi L; Stanghellini V; Bunnett NW; Barbara G; Vergnolle N
    Gastroenterology; 2015 Aug; 149(2):433-44.e7. PubMed ID: 25911511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases.
    Ceuleers H; Van Spaendonk H; Hanning N; Heirbaut J; Lambeir AM; Joossens J; Augustyns K; De Man JG; De Meester I; De Winter BY
    World J Gastroenterol; 2016 Dec; 22(47):10275-10286. PubMed ID: 28058009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post-inflammatory rat model for irritable bowel syndrome.
    Ceuleers H; Hanning N; Heirbaut J; Van Remoortel S; Joossens J; Van Der Veken P; Francque SM; De Bruyn M; Lambeir AM; De Man JG; Timmermans JP; Augustyns K; De Meester I; De Winter BY
    Br J Pharmacol; 2018 Sep; 175(17):3516-3533. PubMed ID: 29911328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAR4: a new role in the modulation of visceral nociception.
    Bradesi S
    Neurogastroenterol Motil; 2009 Nov; 21(11):1129-32. PubMed ID: 19804483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Main ion channels and receptors associated with visceral hypersensitivity in irritable bowel syndrome.
    de Carvalho Rocha HA; Dantas BP; Rolim TL; Costa BA; de Medeiros AC
    Ann Gastroenterol; 2014; 27(3):200-206. PubMed ID: 24976114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E
    Grabauskas G; Wu X; Gao J; Li JY; Turgeon DK; Owyang C
    Gastroenterology; 2020 Jun; 158(8):2195-2207.e6. PubMed ID: 32084424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteases and protease-activated receptors (PARs): novel signals for pain.
    Cenac N; Vergnolle N
    Curr Top Med Chem; 2005; 5(6):569-76. PubMed ID: 16022679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-activated receptor 1 is implicated in irritable bowel syndrome mediators-induced signaling to thoracic human sensory neurons.
    Desormeaux C; Bautzova T; Garcia-Caraballo S; Rolland C; Barbaro MR; Brierley SM; Barbara G; Vergnolle N; Cenac N
    Pain; 2018 Jul; 159(7):1257-1267. PubMed ID: 29554016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.
    Du L; Long Y; Kim JJ; Chen B; Zhu Y; Dai N
    Dig Dis Sci; 2019 Mar; 64(3):729-739. PubMed ID: 30446929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: transient receptor potential channels as possible therapeutic targets in irritable bowel syndrome.
    Beckers AB; Weerts ZZRM; Helyes Z; Masclee AAM; Keszthelyi D
    Aliment Pharmacol Ther; 2017 Nov; 46(10):938-952. PubMed ID: 28884838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of protease-activated receptor type 2 in nociceptive signaling and pain.
    Mrozkova P; Palecek J; Spicarova D
    Physiol Res; 2016 Jul; 65(3):357-67. PubMed ID: 27070742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction.
    Shi HL; Liu CH; Ding LL; Zheng Y; Fei XY; Lu L; Zhou XM; Yuan JY; Xie JQ
    World J Gastroenterol; 2015 Apr; 21(16):4852-63. PubMed ID: 25944998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Serine Proteases as a Novel Therapeutic Strategy for Abdominal Pain in IBS.
    Decraecker L; Boeckxstaens G; Denadai-Souza A
    Front Physiol; 2022; 13():880422. PubMed ID: 35665224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments.
    Farzaei MH; Bahramsoltani R; Abdollahi M; Rahimi R
    J Neurogastroenterol Motil; 2016 Oct; 22(4):558-574. PubMed ID: 27431236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local Colonic Administration of a Serine Protease Inhibitor Improves Post-Inflammatory Visceral Hypersensitivity in Rats.
    Hanning N; De Bruyn M; Ceuleers H; Boogaerts T; Berg M; Smet A; De Schepper HU; Joossens J; van Nuijs ALN; De Man JG; Augustyns K; De Meester I; De Winter BY
    Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34072320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease activated receptor 2: a new target for IBS treatment.
    Bueno L
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():95-102. PubMed ID: 18924448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role of Ca
    Tsubota M; Matsui K; Nakano M; Kajitani R; Ishii Y; Tomochika K; Nishikawa Y; Fukushi S; Yamagata A; Sekiguchi F; Okada T; Toyooka N; Kawabata A
    Eur J Pharmacol; 2020 Nov; 887():173576. PubMed ID: 32949597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.